Genome-wide association study of rate of cognitive decline in Alzheimer’s disease patients identifies novel genes and pathways.

Variability exists in the disease trajectories of Alzheimer’s disease (AD) patients. We performed a genome-wide association study to examine rate of cognitive decline (ROD) in patients with AD.